Atlas Trials

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

Clinical trial NCT01515774 · UNKNOWN

Trial details

NCT number
NCT01515774
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2011-09-01
Primary completion
2012-08-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.